Hypothesis and TheoryPublished 12 October 2026Influencing the exposome, patient macroenvironment, tumor microenvironment through-line to improve clinical outcomesSamuel F. Yanuck · Neil E. AlexisFrontiers in Oncologydoi 10.3389/fonc.2026.1929067
Original ResearchPublished 12 October 2026Multi-cohort screening of PANoptosis-related genes reveals PARP1 as a key target, and AZD5305 exerts anti-tumor effects in neuroblastomaShujun Shi · Zhaoxia Zhang · Junyi Luo · Zhaoying Wang · Tao Mi · Liming Jin · Xiangpan Kong · Jinkui Wang · Junhong Liu · Li Wang · Dawei HeFrontiers in Oncologydoi 10.3389/fonc.2026.1903085
ReviewPublished 12 October 2026Functional single-cell omics in gynecological cancers immunotherapy: from heterogeneity dissection to clinical translationDong-mei Li · Kai-ge Pei · Bo-wen Yang · Ming-rong Qie · Jin-feng Xu · Lan Zhong · Liang SongFrontiers in Immunologydoi 10.3389/fimmu.2026.1981010
ReviewPublished 12 October 2026Nutritional regulation of the tumor immune microenvironment: metabolic mechanisms, immunotherapy response, and nursing implicationsDanwei Zhong · Congjue Li · Zunyao XiaoFrontiers in Immunologydoi 10.3389/fimmu.2026.1938564
Mini ReviewPublished 12 October 2026Spatial heterogeneity in glioblastoma: linking single-cell and spatial multi-omics to vaccine immunotherapyJuan Yuan · Yong LiuFrontiers in Immunologydoi 10.3389/fimmu.2026.1921816
CorrectionPublished 12 October 2026Correction: Effect and mechanism of Emodin on mouse myeloid-derived suppressor cellsFrontiers Production OfficeFrontiers in Pharmacologydoi 10.3389/fphar.2026.2001607
Mini ReviewPublished 9 October 2026Biomarker-guided immunotherapy in osteosarcoma: from immune microenvironment profiling to patient stratification and combination strategiesQingqing LiFrontiers in Medicinedoi 10.3389/fmed.2026.1987146
Original ResearchPublished 9 October 2026Adverse reactions of immune checkpoint inhibitors combined with acetaminophen/non-steroidal anti-inflammatory drugs (NSAIDs): a pharmacovigilance analysis of drug–drug interactionsXiayang Ren · Lihui Xue · Yanfeng Wang · Jian XiaoFrontiers in Pharmacologydoi 10.3389/fphar.2026.1833275
ReviewPublished 7 October 2026Gut mycobiome dysbiosis in digestive system cancers: immune remodeling and translational implicationsLingBo Ma · Zhen Wang · Jie MaoFrontiers in Cellular and Infection Microbiologydoi 10.3389/fcimb.2026.1902754
Systematic ReviewPublished 7 October 2026Global research trends in m 6 A demethylases and cancer: a bibliometric and visualization analysisHao Lei · Hui Guo · Rong Lei · Jumei Sun · Yuanhang Yu · Lei Li · Chunping Liu · Guanghua FuFrontiers in Geneticsdoi 10.3389/fgene.2026.1943884
Original ResearchPublished 6 October 2026scTIME: single-cell-informed interpretable modeling of immunotherapy-associated immune states in non-small cell lung cancerGuozhi Chen · Chenqiu You · Hong Gao · Chengjie XuFrontiers in Artificial Intelligencedoi 10.3389/frai.2026.1918104
Original ResearchPublished 1 October 2026Exploring the immune enhancement effect of radiotherapy combined with NK cells on non-small cell lung cancer based on proteomics technologyCui Chang · Tang Youming · Lu Ying · Lei Ningning · Guo Chunhui · Wei Dekai · Liang Mei · Wu Qiyuan · Liu Gechen · Wu Fasheng · Chen JibingOncology Reviewsdoi 10.3389/or.2026.1853377
Original ResearchPublished 24 September 2026Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic responseErwei Li · Yingying Tang · Yuanyuan Wanyan · Yu LiangFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1903725
Original ResearchPublished 23 September 2026Integrative oxidative stress–disulfidptosis analysis identifies NPR3 and ZNF366 as cell-type-associated candidate markers in clear cell renal cell carcinomaPing Wang · Zhixuan Cai · Gaofeng Wu · Guangfeng ZhuFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1912537
Original ResearchPublished 28 May 2026Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancersFederico Rossari · Michele Sala · Margherita Rimini · Silvia Camera · Mara Persano · Giovanni Tonon · Chiara Bonini · Maria Giulia Cangi · Lorenza Pecciarini · Claudio Doglioni · Maurilio Ponzoni · Chiara Balestrieri · Federica Pedica · Andrea Casadei-GardiniPathology and Oncology Researchdoi 10.3389/pore.2026.1612389